Sanara Medtech Inc SMTI:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/20/22 EDT
23.01quote price arrow up+0.83 (+3.72%)
Volume
22,829
52 week range
17.41 - 43.89
Loading...
  • Open22.49
  • Day High24.45
  • Day Low22.41
  • Prev Close22.18
  • 52 Week High43.89
  • 52 Week High Date07/28/21
  • 52 Week Low17.41
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap183.62M
  • Shares Out7.98M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.25
  • YTD % Change-22.13

KEY STATS

  • Open22.49
  • Day High24.45
  • Day Low22.41
  • Prev Close22.18
  • 52 Week High43.89
  • 52 Week High Date07/28/21
  • 52 Week Low17.41
  • 52 Week Low Date05/10/22
  • Market Cap183.62M
  • Shares Out7.98M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.25
  • YTD % Change-22.13

RATIOS/PROFITABILITY

  • EPS (TTM)-1.31
  • P/E (TTM)-17.59
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-8.36M
  • ROE (TTM)-30.36%
  • Revenue (TTM)26.95M
  • Gross Margin (TTM)90.20%
  • Net Margin (TTM)-36.99%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sanara Medtech Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical and chronic wound and skin care markets. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin...
Ronald Nixon
Executive Chairman of the Board
Zachary Fleming
Chief Executive Officer
Michael McNeil
Chief Financial Officer
Address
1200 Summit Ave Ste 414
Fort Worth, TX
76102-4407
United States